A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged as a promising active agent against tumors of the central nervous ...
A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged as a promising active agent against tumors of the central nervous ...
NEJM Evidence, a journal of the New England Journal of Medicine Group, has published an article titled "Validation of a Saliva microRNA Signature for Endometriosis," dedicated to the saliva-based ...
STOCKHOLM − U.S. scientists Victor Ambros and Gary Ruvkun won the 2024 Nobel Prize in Medicine for the discovery of microRNA and its crucial role in how multicellular organisms grow and live, the ...
The Times of Israel on MSN
In world first, Israeli scientists use RNA-based gene therapy to stop ALS deterioration
By adding a microRNA molecule to ALS models, Tel Aviv University, Ben-Gurion University and Weizmann Institute researchers say the damaged nerve cells 'even regenerated' The post In world first, ...
A novel angiogenic microRNA drug might be a new option for the treatment of ischemic cardiovascular disease, according to a new study (“Nuclear microRNA-466c regulates Vegfa expression in response to ...
Victor Ambros receives funding from the U.S. National Institutes of Health. The Conversation Weekly podcast caught up with Victor Ambros from his lab at the UMass Chan Medical School to learn more ...
A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported Monday (Sept. 4 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback